Abiraterone offers men whose prostate cancer has come back after chemotherapy crucial extra months of life. Before this decision, they would have been told it is too expensive for the NHS, and only been given access through the Cancer Drugs Fund. But now they will be given the drug routinely on the NHS and without any delay.
16 May 2012
The University of Queensland Diamantina Institute's researchers have played a leading role in a recent study into osteoporosis, more than doubling the number of currently known genes in the disease. In their study published in the leading genetic journal Nature Genetics, variants in 56 regions of the genome have been discovered to influence the bone mineral density (BMD) of individuals
30 April 2012
A common cancer drug and a drug used for a rare condition affecting the heart could together treat an aggressive form of lung cancer called non-small cell lung cancer (NSCLC), according to a study published in Cell.
26 April 2012
ew research carried out by a University of Dundee scientist could lead to new uses for one of the world’s oldest medicines.
20 April 2012
Proteome Sciences plc (“Proteome Sciences”) announces that Euro-HYP-1, a consortium of leading academic, clinical and industrial European partners in which it is a member, has been awarded a near €11m grant under the EU Framework 7 programme for new ground breaking research on the treatment of stroke.
19 March 2012
An ancient Incan toothache remedy – for centuries handed down among an indigenous people in the rainforests of Peru – could be on the cusp of revolutionising worldwide dental practice.
14 March 2012
As Brain Awareness Week (12–18 March) gets underway in the UK, the preliminary findings from the latest tinnitus research suggest that hearing aids might help tinnitus sufferers; research is ongoing into the role the brain has, and how tinnitus symptoms are reflected in brain network activity.
13 March 2012
Cancer Research UK and its commercial arm, Cancer Research Technology have developed a unique test to discover molecules that could lead to potential new treatments for oestrogen receptor (ER)-positive breast cancer.
06 March 2012
The University of Dundee has received over £10 million from the Wellcome Trust in the fight against some of the world’s most neglected parasitic diseases, including support for a multi-million pound partnership with GlaxoSmithKline (GSK) to discover new drug treatments.
06 March 2012
Cancer Research UK scientists have revealed how a combination of two very different drugs, currently being tested in clinical trials, amplifies the destruction of pancreatic cancer cells, according to research published in the Journal of Experimental Medicine, today (Monday).
20 February 2012
The Scottish Medicines Consortium (SMC) has issued positive final guidance for RoActemra, the UK’s first specifically licensed, effective biologic treatment for systemic juvenile idiopathic arthritis (SJIA).
14 February 2012
The most recent issue of Drug Discovery Today: Therapeutic Strategies, edited by Chris Lipinski, deals with the exciting topic of drug repurposing. The twelve articles selected for this issue were intended to highlight the “state-of-the-art” of this growing discipline.
13 February 2012
Psychiatric drugs are as effective as drugs used to treat many physical health problems, according to a major review published in the February issue of the British Journal of Psychiatry.
01 February 2012
Cancer Research UK scientists have created the first 3D structure of a key protein that protects against the development of cancer, according to research published in Nature Structural & Molecular Biology.
23 January 2012
Pain therapy drug developers address the rapid rise in prescription drug abuse alongside the need for safe and effective treatments for a growing number of chronic pain sufferers. The sector has a diverse pipeline, with reformulations of existing therapies and alternative modes of drug delivery in development alongside novel compounds. However, increased generic competition will temper market growth over the next decade.
23 January 2012
Development charity Sightsavers has today unveiled a 10-year campaign to help eliminate one of the world’s leading causes of preventable blindness, termed onchocerciasis (also river blindness). With plans to fundraise and invest more than £27 million over the next decade to help combat this neglected tropical disease (NTD) across Africa, the charity is starting work this month in the Democratic Republic of the Congo where the disease is endemic.
17 January 2012
Scientists based at Cancer Research UK’s Cambridge Research Institute have discovered how receptors for the female sex hormone oestrogen attach to a different part of the DNA in breast cancer patients who are more likely to relapse, according to a study published in Nature.
05 January 2012
UK Biobank launches its Access Procedures today (Wednesday 14th), which govern the way the resource can be used by scientists to improve the health of future generations.
14 December 2011
A new pooled analysis presented today at the International Diabetes Federation (IDF) 21st World Diabetes Congress has demonstrated that people with type 2 diabetes taking 'Januvia' (sitagliptin) experienced a lower incidence of major cardiovascular (CV) events (MACE) compared to those treated with a sulphonylurea (SU).
06 December 2011
Pantarhei Bioscience, a specialty pharmaceutical company focusing on the development of innovative, proprietary treatments in the fields of women’s health and endocrine cancer, announces the publication in the Journal of the Federation of American Societies for Experimental Biology (FASEB J October 5, 2011) of the results of an innovative treatment strategy for ovarian cancer, which has now been selected to appear in the Faculty of 1000 (F1000) emphasizing its significance.
15 November 2011